While the long‐term effects of Cathepsin B inhibition, including potential lysosomal dysfunction or off‐target interactions, have not been explicitly investigated in this study, the inhibitors utilized have been previously approved for the treatment of cancer, neurological, cardiovascular, and other diseases. This evidence concerns the gene CTSB and cancer.